US EditionPublished • loading... • Updated
Abreu advises Grupo IMG on C2 Capital investment
Summary by Iberian Lawyer
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Abreu advises Grupo IMG on C2 Capital investment
Abreu Advogados has advised Grupo IMG on C2 Capital’s investment in Everbio, a subsidiary of Evertis Ibérica, through the issuance of convertible bonds worth €15 million. Everbio, established in 2024 by Grupo IMG, was created with the goal of unifying the R&D activities of the companies within the Grupo IMG, previously dispersed across Evertis, Selenis, and Renascis. This investment is part of Grupo IMG’s investment plan of approximately €39.5 m…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
